FARALLON CAPITAL MANAGEMENT LLC - Q1 2021 holdings

$20.1 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 238 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 105.1% .

 Value Shares↓ Weighting
SPY BuySPDR S&P 500 ETF TRput$885,798,000
+73.6%
2,235,000
+63.7%
4.40%
+43.4%
ALXN BuyALEXION PHARMACEUTICALS INC$883,055,000
+151.5%
5,775,000
+157.0%
4.39%
+107.9%
GOOG BuyALPHABET INCcap stk cl c$836,453,000
+32.2%
404,351
+12.0%
4.16%
+9.2%
IQV BuyIQVIA HLDGS INC$785,922,000
+8.5%
4,069,181
+0.6%
3.90%
-10.4%
WLTW BuyWILLIS TOWERS WATSON PLC LTD$715,067,000
+252.6%
3,124,200
+224.6%
3.55%
+191.2%
AON BuyAON PLC$564,735,000
+17.7%
2,454,194
+8.0%
2.81%
-2.8%
TMO BuyTHERMO FISHER SCIENTIFIC INC$527,154,000
+1.6%
1,155,078
+3.7%
2.62%
-16.1%
TMUS BuyT-MOBILE US INC$514,795,000
-3.3%
4,108,826
+4.0%
2.56%
-20.1%
BSX SellBOSTON SCIENTIFIC CORP$495,604,000
+4.1%
12,822,869
-3.1%
2.46%
-13.9%
XLNX BuyXILINX INC$457,934,000
+26.4%
3,696,000
+44.6%
2.28%
+4.5%
MSFT BuyMICROSOFT CORP$451,794,000
+15.5%
1,916,248
+9.0%
2.24%
-4.5%
FIS SellFIDELITY NATL INFORMATION SV$441,841,000
-0.8%
3,142,318
-0.2%
2.20%
-18.0%
FB BuyFACEBOOK INCcl a$412,108,000
+30.7%
1,399,205
+21.2%
2.05%
+8.0%
ARMK SellARAMARK$410,610,000
-3.2%
10,868,450
-1.4%
2.04%
-20.0%
WAB SellWABTEC$391,600,000
+7.1%
4,946,946
-1.0%
1.95%
-11.5%
RTX BuyRAYTHEON TECHNOLOGIES CORP$369,537,000
+13.8%
4,782,411
+5.3%
1.84%
-6.0%
CNC SellCENTENE CORP DEL$359,494,000
-12.6%
5,625,000
-17.9%
1.79%
-27.8%
XLRN  ACCELERON PHARMA INC$352,586,000
+6.0%
2,600,0000.0%1.75%
-12.4%
MA NewMASTERCARD INCORPORATEDcl a$351,037,000985,920
+100.0%
1.74%
BX BuyBLACKSTONE GROUP INC$330,251,000
+30.9%
4,431,121
+13.9%
1.64%
+8.2%
AVGO BuyBROADCOM INC$316,331,000
+16.0%
682,247
+9.5%
1.57%
-4.2%
IPHI BuyINPHI CORP$311,290,000
+56.5%
1,744,800
+40.7%
1.55%
+29.2%
CRM BuySALESFORCE COM INC$302,312,000
-3.6%
1,426,875
+1.3%
1.50%
-20.4%
ANTM SellANTHEM INC$296,134,000
-27.7%
825,000
-35.3%
1.47%
-40.2%
WORK BuySLACK TECHNOLOGIES INC$293,645,000
+41.5%
7,227,300
+47.1%
1.46%
+16.9%
SHW BuySHERWIN WILLIAMS CO$291,618,000
+1.9%
395,141
+1.5%
1.45%
-15.8%
TRU BuyTRANSUNION$284,407,000
+65.3%
3,160,077
+82.2%
1.41%
+36.5%
CHTR SellCHARTER COMMUNICATIONS INC Ncl a$280,237,000
-22.5%
454,178
-17.0%
1.39%
-36.0%
GWPH NewGW PHARMACEUTICALS PLCads$277,393,0001,278,900
+100.0%
1.38%
V SellVISA INC$277,118,000
-43.1%
1,308,829
-41.3%
1.38%
-53.0%
MXIM BuyMAXIM INTEGRATED PRODS INC$270,218,000
+97.6%
2,957,400
+91.7%
1.34%
+63.4%
AMRS SellAMYRIS INC$257,850,000
+138.6%
13,500,000
-22.9%
1.28%
+97.1%
EXEL SellEXELIXIS INC$242,843,000
+10.0%
10,750,000
-2.3%
1.21%
-9.1%
HLT BuyHILTON WORLDWIDE HLDGS INC$235,726,000
+29.2%
1,949,437
+18.8%
1.17%
+6.6%
BBL NewBHP GROUP PLCsponsored adr$231,470,0004,000,521
+100.0%
1.15%
EDU BuyNEW ORIENTAL ED & TECHNOLOGYspon adr$223,202,000
+4.1%
15,943,000
+1281.2%
1.11%
-14.0%
FATE SellFATE THERAPEUTICS INC$156,655,000
-42.6%
1,900,000
-36.7%
0.78%
-52.6%
BABA SellALIBABA GROUP HLDG LTDsponsored ads$153,360,000
-22.8%
676,400
-20.7%
0.76%
-36.2%
IOVA SellIOVANCE BIOTRAPEUTICS INC$150,385,000
-46.0%
4,750,000
-20.8%
0.75%
-55.4%
MRTX SellMIRATI THERAPEUTICS INC$145,605,000
-24.2%
850,000
-2.9%
0.72%
-37.4%
LU BuyLUFAX HOLDING LTD$142,781,000
+87.7%
9,833,399
+83.5%
0.71%
+54.8%
ASND  ASCENDIS PHARMA A/Ssponsored adr$128,880,000
-22.7%
1,000,0000.0%0.64%
-36.2%
QGEN SellQIAGEN NV$123,596,000
-28.2%
2,538,423
-22.1%
0.61%
-40.7%
NYT SellNEW YORK TIMES COcl a$120,456,000
-64.5%
2,379,622
-63.6%
0.60%
-70.6%
EFX BuyEQUIFAX INC$109,879,000
+53.7%
606,629
+63.7%
0.55%
+27.0%
PLYA  PLAYA HOTELS & RESORTS NV$109,463,000
+22.7%
14,994,8670.0%0.54%
+1.3%
ALNY BuyALNYLAM PHARMACEUTICALS INC$98,833,000
+117.3%
700,000
+100.0%
0.49%
+79.2%
ENTA BuyENANTA PHARMACEUTICALS INC$98,393,000
+31.7%
1,995,000
+12.4%
0.49%
+8.9%
 MOMO INCnote 1.250% 7/0$96,829,000
+3.6%
110,077,0000.0%0.48%
-14.4%
HWM SellHOWMET AEROSPACE INC$94,968,000
-32.0%
2,955,729
-39.6%
0.47%
-43.8%
APLS SellAPELLIS PHARMACEUTICALS INC$93,329,000
-28.3%
2,175,000
-4.4%
0.46%
-40.7%
GBIO BuyGENERATION BIO CO$93,078,000
+44.7%
3,270,500
+44.1%
0.46%
+19.6%
PCG  PG&E CORP$85,390,000
-6.0%
7,292,0420.0%0.42%
-22.3%
KRTX SellKARUNA THERAPEUTICS INC$81,155,000
+14.1%
675,000
-3.6%
0.40%
-5.8%
CLGX BuyCORELOGIC INC$77,269,000
+74.1%
975,000
+69.9%
0.38%
+43.8%
BCAB SellBIOATLA INC$75,856,000
+13.4%
1,492,060
-24.1%
0.38%
-6.2%
 IQIYI INCnote 2.000% 4/0$75,715,000
+5.5%
81,762,0000.0%0.38%
-13.0%
BRMK  BROADMARK RLTY CAP INC$75,000,000
+2.5%
7,170,2130.0%0.37%
-15.2%
RVMD NewREVOLUTION MEDICINES INC$73,854,0001,609,730
+100.0%
0.37%
BPMC NewBLUEPRINT MEDICINES CORP$67,555,000694,791
+100.0%
0.34%
AGIO BuyAGIOS PHARMACEUTICALS INC$64,550,000
+49.0%
1,250,000
+25.0%
0.32%
+23.0%
KSU SellKANSAS CITY SOUTHERN$63,341,000
-12.4%
240,000
-32.3%
0.32%
-27.6%
PTGX  PROTAGONIST THERAPEUTICS INC$62,808,000
+28.5%
2,425,0000.0%0.31%
+6.1%
ARNA BuyARENA PHARMACEUTICALS INC$58,982,000
+2.4%
850,000
+13.3%
0.29%
-15.6%
FGEN SellFIBROGEN INC$58,441,000
-17.1%
1,683,700
-11.4%
0.29%
-31.6%
CYTK BuyCYTOKINETICS INC$58,150,000
+16.6%
2,500,000
+4.2%
0.29%
-3.7%
 THERAVANCE BIOPHARMA INCnote 3.250%11/0$57,933,000
+7.7%
56,695,0000.0%0.29%
-11.1%
BuyINSMED INCnote 1.750% 1/1$56,619,000
+54.9%
50,000,000
+53.8%
0.28%
+27.7%
PRAH NewPRA HEALTH SCIENCES INC$53,666,000350,000
+100.0%
0.27%
CARA  CARA THERAPEUTICS INC$53,515,000
+43.5%
2,465,0000.0%0.27%
+18.8%
APHA NewAPHRIA INC$50,808,0002,765,800
+100.0%
0.25%
LNTH SellLANTHEUS HLDGS INC$48,083,000
+34.5%
2,250,000
-15.1%
0.24%
+11.2%
KRYS BuyKRYSTAL BIOTECH INC$48,150,000
+52.9%
625,000
+19.0%
0.24%
+26.5%
BEAM NewBEAM THERAPEUTICS INC$47,422,000592,481
+100.0%
0.24%
TPTX NewTURNING POINT THERAPEUTICS I$47,295,000500,000
+100.0%
0.24%
 ATENTO S A$46,815,000
+156.8%
2,230,3570.0%0.23%
+111.8%
RDUS  RADIUS HEALTH INC$43,960,000
+16.8%
2,107,4000.0%0.22%
-3.5%
ZGNX  ZOGENIX INC$43,920,000
-2.4%
2,250,0000.0%0.22%
-19.6%
ANNX SellANNEXON INC$40,531,000
+4.0%
1,455,846
-6.5%
0.20%
-14.1%
 CLOVIS ONCOLOGY INCnote 1.250% 5/0$39,243,000
+8.8%
51,910,0000.0%0.20%
-10.1%
IKNA NewIKENA ONCOLOGY INC$38,124,0001,349,513
+100.0%
0.19%
RP NewREALPAGE INC$36,188,000415,000
+100.0%
0.18%
QTRX NewQUANTERIX CORP$35,082,000600,000
+100.0%
0.17%
CHNG NewCHANGE HEALTHCARE INC$32,125,0001,453,600
+100.0%
0.16%
NVAX SellNOVAVAX INC$31,729,000
+3.5%
175,000
-36.4%
0.16%
-14.1%
COHR NewCOHERENT INC$31,611,000125,000
+100.0%
0.16%
PLRX  PLIANT THERAPEUTICS INC$30,058,000
+73.1%
764,2620.0%0.15%
+43.3%
 IQIYI INCnote 3.750%12/0$29,643,000
-0.8%
29,689,0000.0%0.15%
-18.3%
BIIB  BIOGEN INC$28,814,000
+14.2%
103,0000.0%0.14%
-5.9%
IONS SellIONIS PHARMACEUTICALS INC$28,347,000
-33.2%
630,500
-15.9%
0.14%
-44.7%
KVSC NewKHOSLA VENTURES ACQUT CO III$28,062,0002,809,000
+100.0%
0.14%
VAR NewVARIAN MED SYS INC$26,480,000150,000
+100.0%
0.13%
NUVB NewNUVATION BIO INC$26,125,0002,500,000
+100.0%
0.13%
SAGE SellSAGE THERAPEUTICS INC$25,823,000
-71.6%
345,000
-67.1%
0.13%
-76.6%
SellKARYOPHARM THERAPEUTICS INCnote 3.000%10/1$25,538,000
-41.3%
25,000,000
-28.6%
0.13%
-51.5%
BuyISIS PHARMACEUTICALS INC DELnote 1.000%11/1$24,797,000
+807.3%
24,435,000
+877.4%
0.12%
+668.8%
TGTX BuyTG THERAPEUTICS INC$24,100,000
+363.3%
500,000
+400.0%
0.12%
+287.1%
CLVR SellCLEVER LEAVES HOLDINGS INC$23,441,000
-18.4%
2,278,079
-8.1%
0.12%
-32.9%
CNST BuyCONSTELLATION PHARMCETICLS I$23,390,000
+8.3%
1,000,000
+33.3%
0.12%
-10.8%
ORTX NewORCHARD THERAPEUTICS PLCads$23,344,0003,215,434
+100.0%
0.12%
KVSB NewKHOSLA VENTURES ACQUSTN CO I$22,703,0002,250,000
+100.0%
0.11%
SRPT SellSAREPTA THERAPEUTICS INC$22,359,000
-78.1%
300,000
-50.0%
0.11%
-82.0%
 IQIYI INCnote 4.000%12/1$20,685,000
+3.4%
20,000,0000.0%0.10%
-14.2%
REVHU NewREVOLUTION HEALTHCAR AQ CORPunit 03/18/20266$20,100,0002,000,000
+100.0%
0.10%
DCRCU NewDECARBONIZATION PLUS ACQU IIunit 03/19/2026$19,920,0002,000,000
+100.0%
0.10%
ZYME SellZYMEWORKS INC$18,948,000
-46.5%
600,000
-20.0%
0.09%
-55.9%
FPRX BuyFIVE PRIME THERAPEUTICS INC$18,896,000
+177.7%
501,618
+25.4%
0.09%
+129.3%
FVIVU NewFORTRESS VALUE ACQUISI CORPunit 03/31/2028$17,325,0001,750,000
+100.0%
0.09%
RC SellREADY CAPITAL CORP$16,778,000
-0.2%
1,250,226
-7.4%
0.08%
-17.8%
ACHL NewACHILLES THERAPEUTICS PLCsponsored ads$16,550,0001,000,000
+100.0%
0.08%
ZEAL  ZEALAND PHARMA A/Ssponsored adr$16,300,000
-11.1%
510,0000.0%0.08%
-26.4%
NewNOVAVAX INCnote 3.750% 2/0$16,100,00010,000,000
+100.0%
0.08%
RCEL NewAVITA MEDICAL INC$15,856,000800,000
+100.0%
0.08%
BEKE SellKE HLDGS INCsponsored ads$15,556,000
-26.3%
273,000
-20.4%
0.08%
-39.4%
RCKT BuyROCKET PHARMACEUTICALS INC$15,530,000
+41.6%
350,000
+75.0%
0.08%
+16.7%
ASZU NewAUSTERLITZ ACQUISITION CORPunit 99/99/9999$15,045,0001,500,000
+100.0%
0.08%
KAHCU NewKKR ACQUISITION HOLDING I COunit 99/99/9999$15,015,0001,500,000
+100.0%
0.08%
ADVM  ADVERUM BIOTECHNOLOGIES INC$14,790,000
-9.0%
1,500,0000.0%0.07%
-25.5%
STAY NewEXTENDED STAY AMER INCunit 99/99/9999b$14,131,000715,499
+100.0%
0.07%
DISAU NewDISRUPTIVE ACQUISITION CORPunit 03/06/2026$13,832,0001,400,000
+100.0%
0.07%
DCPH  DECIPHERA PHARMACEUTICALS IN$13,452,000
-21.4%
300,0000.0%0.07%
-35.0%
LBPH NewLONGBOARD PHARMACEUTICALS IN$13,276,000810,500
+100.0%
0.07%
 NUANCE COMMUNICATIONS INCdbcv 1.000%12/1$12,942,000
-0.8%
7,000,0000.0%0.06%
-19.0%
CMRX NewCHIMERIX INC$12,532,0001,300,000
+100.0%
0.06%
FRXBU NewFOREST ROAD ACQUISITION CORunit 99/99/9999$12,450,0001,250,000
+100.0%
0.06%
GRFS SellGRIFOLS S Asp adr rep b nvt$12,139,000
-41.0%
702,110
-37.0%
0.06%
-51.6%
INBX BuyINHIBRX INC$12,042,000
-28.4%
600,000
+17.6%
0.06%
-40.6%
AGGRU NewAGILE GROWTH CORPunit 03/09/2026$11,904,0001,200,000
+100.0%
0.06%
NewDARIOHEALTH CORP$11,556,000600,000
+100.0%
0.06%
ARWR BuyARROWHEAD PHARMACEUTICALS IN$11,435,000
+120.5%
172,454
+155.1%
0.06%
+83.9%
KURA BuyKURA ONCOLOGY INC$11,308,000
+177.0%
400,000
+220.0%
0.06%
+124.0%
CRIS BuyCURIS INC$11,320,000
+90.6%
1,000,000
+37.9%
0.06%
+55.6%
TINV NewTIGA ACQUISITION CORP$10,843,0001,080,000
+100.0%
0.05%
NGM NewNGM BIOPHARMACEUTICALS INC$10,901,000375,000
+100.0%
0.05%
RKTAU NewROCKET INTERNET GRWT OPRT COunit 99/99/9999$10,010,0001,000,000
+100.0%
0.05%
AACU NewARES ACQUISITION CORPORATIONunit 99/99/9999$10,000,0001,000,000
+100.0%
0.05%
CVIIU NewCHURCHILL CAPITAL CORP VIIunit 99/99/9999$9,970,0001,000,000
+100.0%
0.05%
PS NewPLURALSIGHT INC$10,053,000450,000
+100.0%
0.05%
SellDERMTECH INC$10,158,000
-63.6%
200,000
-76.8%
0.05%
-70.2%
QURE  UNIQURE NV$10,107,000
-6.8%
300,0000.0%0.05%
-23.1%
FMIVU NewFORUM MERGER IV CORPunit 03/15/2028$9,900,0001,000,000
+100.0%
0.05%
FSII NewFS DEVELOPMENT CORP II$9,960,0001,000,000
+100.0%
0.05%
TWNTU NewTAILWIND TWO ACQUISITION CORunit 03/01/2028$9,880,0001,000,000
+100.0%
0.05%
VGIIU NewVIRGIN GROUP ACQUISIT CORP Iunit 99/99/9999$9,930,0001,000,000
+100.0%
0.05%
CRZNU NewCORAZON CAPITAL V838 MONOCERunit 03/24/2026$9,950,0001,000,000
+100.0%
0.05%
CAS NewCASCADE ACQUISITION CORP$9,702,000990,000
+100.0%
0.05%
AVRO SellAVROBIO INC$9,391,000
-15.3%
740,000
-6.9%
0.05%
-29.9%
 GOSSAMER BIO INCnote 5.000% 6/0$8,889,000
-1.6%
10,000,0000.0%0.04%
-18.5%
ALBO  ALBIREO PHARMA INC$8,813,000
-6.0%
250,0000.0%0.04%
-21.4%
SVRA SellSAVARA INC$8,582,000
+67.6%
4,125,877
-7.3%
0.04%
+38.7%
ARYD NewARYA SCIENCES ACQU CORP IVcl a$8,320,000800,000
+100.0%
0.04%
BOLT NewBOLT BIOTRAPEUTICS INC$8,228,000250,000
+100.0%
0.04%
JWSMU NewJAWS MUSTANG ACQUISITION CORunit 99/99/9999$8,120,000800,000
+100.0%
0.04%
LVRAU NewLEVERE HOLDINGS CORPunit 03/09/2026$7,968,000800,000
+100.0%
0.04%
SURF  SURFACE ONCOLOGY INC$7,800,000
-15.6%
1,000,0000.0%0.04%
-30.4%
KNTE  KINNATE BIOPHARMA INC$7,790,000
-21.7%
250,0000.0%0.04%
-35.0%
RACB NewRESEARCH ALLIANCE CORP II$7,688,000750,000
+100.0%
0.04%
GMIIU NewGORES METROPOULOS II INCunit 01/31/2028$7,590,000750,000
+100.0%
0.04%
WPCAU NewWARBURG PINCUS CAPTAL CORP Iunit 99/99/9999$7,560,000750,000
+100.0%
0.04%
APGBU NewAPOLLO STRATEGIC GRWT CPTL Iunit 99/99/9999$7,485,000750,000
+100.0%
0.04%
WPCBU NewWARBURG PINCUS CAPTAL CORP Iunit 99/99/9999$7,485,000750,000
+100.0%
0.04%
VAQC NewVECTOR ACQUISITION CORP II$7,425,000750,000
+100.0%
0.04%
GSEVU NewGORES HOLDINGS VII INCunit 02/12/2028$7,470,000750,000
+100.0%
0.04%
SLACU NewSOCIAL LEVERAGE ACQUISN CORPunit 99/99/9999$7,463,000750,000
+100.0%
0.04%
CNTB NewCONNECT BIOPHARMA HLDGS LTDads$7,400,000400,000
+100.0%
0.04%
TBCPU NewTHUNDER BRIDGE CAP PRTNRS IIunit 02/15/2028$7,418,000750,000
+100.0%
0.04%
RTPYU NewREINVENT TECHNOLOGY PARTNERSunit 03/12/2026$7,530,000750,000
+100.0%
0.04%
PFDRU NewPATHFINDER ACQUISITION CORPunit 02/17/2026$7,425,000750,000
+100.0%
0.04%
ACTDU NewARCLIGHT CLEAN TRANSITION IIunit 03/16/2028$7,500,000750,000
+100.0%
0.04%
STREU NewSUPERNOVA PARTN ACQ CO III Lunit 99/99/9999$7,000,000700,000
+100.0%
0.04%
NXUU NewNOVUS CAPITAL CORPORATION IIunit 99/99/9999$7,000,000700,000
+100.0%
0.04%
 RADIUS HEALTH INCnote 3.000% 9/0$6,435,000
+7.3%
6,783,0000.0%0.03%
-11.1%
FNCH NewFINCH THERAPEUTICS GROUP INC$6,205,000390,000
+100.0%
0.03%
IMGN SellIMMUNOGEN INC$6,075,000
-5.8%
750,000
-25.0%
0.03%
-23.1%
GTPBU NewGORES TECHNOLOGY PARTNERS IIunit 03/16/2028$5,982,000600,000
+100.0%
0.03%
FSRXU NewFINSERV ACQUISITION CORP IIunit 02/17/2026$5,979,000600,000
+100.0%
0.03%
KVSA NewKHOSLA VENTURES ACQUISITIONcl a$6,060,000600,000
+100.0%
0.03%
RXRAU NewRXR ACQUISITION CORPunit 01/01/2025$5,910,000600,000
+100.0%
0.03%
IPVIU NewINTERPRIVATE IV INFRATECH PRunit 03/05/2026$5,934,000600,000
+100.0%
0.03%
PHVS NewPHARVARIS N V$5,612,000200,000
+100.0%
0.03%
COGT  UNUM THERAPEUTICS INC$5,268,000
-21.8%
600,0000.0%0.03%
-36.6%
CGEM NewCULLINAN ONCOLOGY INC$5,209,000125,000
+100.0%
0.03%
INNV NewINNOVAGE HLDG CORP$5,158,000200,000
+100.0%
0.03%
TBA NewTHOMA BRAVO ADVANTAGE$5,225,000500,000
+100.0%
0.03%
HARP NewHARPOON THERAPEUTICS INC$5,230,000250,000
+100.0%
0.03%
LCAHU NewLANDCADIA HOLDINGS IV INCunit 05/01/2025$4,950,000500,000
+100.0%
0.02%
SRNGU NewSOARING EAGLE ACQUISITION COunit 02/23/2026$5,060,000500,000
+100.0%
0.02%
FWAA NewFIFTH WALL ACQUISITION CORP$5,000,000500,000
+100.0%
0.02%
HERAU NewFTAC HERA ACQUISITION CORPunit 02/28/2026$4,995,000500,000
+100.0%
0.02%
GSQDU NewG SQUARED ASCEND I INCunit 99/99/9999$5,000,000500,000
+100.0%
0.02%
AUSU NewAUSTERLITZ ACQUISITION CORPunit 99/99/9999$5,020,000500,000
+100.0%
0.02%
 APELLIS PHARMACEUTICALS INCnote 3.500% 9/1$4,886,000
-17.6%
3,522,0000.0%0.02%
-33.3%
CLAAU NewCOLONNADE ACQUISITION CORP Iunit 99/99/9999$4,925,000500,000
+100.0%
0.02%
EQ SellEQUILLIUM INC$4,862,000
+29.8%
680,000
-2.9%
0.02%
+4.3%
SCOBU NewSCION TECH GROWTH IIunit 99/99/9999$4,482,000450,000
+100.0%
0.02%
IPVAU NewINTERPRIVATE II ACQUISITIONunit 99/99/9999$3,956,000400,000
+100.0%
0.02%
IPVFU NewINTERPRIVATE III FINANCIAL Punit 99/99/9999$3,944,000400,000
+100.0%
0.02%
HMCO NewHUMANCO ACQUISITION CORP$4,069,000408,900
+100.0%
0.02%
GIIXU NewGORES HLDGS VIII INCunit 02/01/2028$4,000,000400,000
+100.0%
0.02%
NDACU NewNIGHTDRAGON ACQUISITION CORPunit 02/26/20266$4,080,000400,000
+100.0%
0.02%
FRSGU NewFIRST RESERVE SUSTAINABLE GWunit 03/05/2026$4,014,000400,000
+100.0%
0.02%
CCVIU NewCHURCHILL CAPITAL CORP VIunit 99/99/9999$4,024,000400,000
+100.0%
0.02%
KURIU NewALKURI GLOBAL ACQUISITION COunit 01/01/2028$3,952,000400,000
+100.0%
0.02%
VPCCU NewVPC IMPACT ACQU HOLDI III INunit 99/99/9999$3,948,000400,000
+100.0%
0.02%
AFMD NewAFFIMED N V$3,955,000500,000
+100.0%
0.02%
CMIIU NewCM LIFE SCIENCES II INCunit 02/25/2028$3,200,000250,000
+100.0%
0.02%
SGFY NewSIGNIFY HEALTH INC$2,926,000100,000
+100.0%
0.02%
LGVU NewLONGVIEW ACQUISITION CORP IIunit 99/99/9999$3,059,000304,698
+100.0%
0.02%
LGACU NewLAZARD GROWTH ACQUISITION COunit 99/99/9999$3,000,000300,000
+100.0%
0.02%
NGAB NewNORTHERN GENESIS ACQUISITION$2,758,000278,026
+100.0%
0.01%
DGNU NewDRAGONEER GROWTH OPT CORP II$2,528,000250,000
+100.0%
0.01%
ACRS NewACLARIS THERAPEUTICS INC$2,520,000100,000
+100.0%
0.01%
SVFA NewSVF INVESTMENT CORP$2,553,000250,000
+100.0%
0.01%
HIIIU NewHUDSON EXECUTIVE INVES IIIunit 02/22/2026$2,480,000250,000
+100.0%
0.01%
GTPAU NewGORES TECHNOLOGY PARTNERS INunit 03/16/2028$2,508,000250,000
+100.0%
0.01%
LOKMU NewLIVE OAK MOBILITY ACQUISI COunit 03/01/2028$2,495,000250,000
+100.0%
0.01%
SNIIU NewSUPERNOVA PARTNERS ACQUISTNunit 99/99/9999$2,008,000200,000
+100.0%
0.01%
VPCBU NewVPC IMPACT ACQUISITION HLDGunit 03/05/2026$1,972,000200,000
+100.0%
0.01%
ANACU NewARCTOS NORTHSTAR ACQUIS CORPunit 99/99/9999$1,998,000200,000
+100.0%
0.01%
LDHAU NewLDH GROWTH CORP Iunit 03/17/2026$1,518,000150,000
+100.0%
0.01%
BRMKWS  BROADMARK RLTY CAP INC*w exp 11/15/202$1,636,000
-15.5%
7,174,6130.0%0.01%
-33.3%
PMGMU NewPRIVETERRA ACQUISITION CORPunit 99/99/9999$1,491,000150,000
+100.0%
0.01%
TMACU NewTHE MUSIC ACQUISITION CORPunit 99/99/9999$1,248,000125,000
+100.0%
0.01%
NSTDU NewNORTHERN STAR INVEST CORP IVunit 02/25/2028$992,000100,000
+100.0%
0.01%
CFVIU NewCF ACQUISITION CORP VIunit 99/99/9999$990,000100,000
+100.0%
0.01%
FOLD SellAMICUS THERAPEUTICS INC$988,000
-96.6%
100,000
-92.0%
0.01%
-97.1%
NSTCU NewNORTHERN STAR INVEST CORP IIunit 02/25/2028$995,000100,000
+100.0%
0.01%
ASPCU NewALPHA CAPITAL ACQUISITION COunit 02/16/2026$792,00079,598
+100.0%
0.00%
CEREW  CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202$566,000
-25.3%
134,1750.0%0.00%
-40.0%
SLAMU NewSLAM CORPunit 99/99/9999$699,00070,508
+100.0%
0.00%
SPAQU NewSPARTAN ACQUISITION CORP IIIunit 99/99/9999$602,00060,053
+100.0%
0.00%
GOL  GOL LINHAS AEREAS INTELIGENTspon adr pfd new$657,000
-22.1%
85,8380.0%0.00%
-40.0%
TINVWS NewTIGA ACQUISITION CORP*w exp 11/06/202$702,000540,000
+100.0%
0.00%
CASWS NewCASCADE ACQUISITION CORP*w exp 11/30/202$446,000495,000
+100.0%
0.00%
HMCOW NewHUMANCO ACQUISITION CORP*w exp 99/99/999$264,000200,000
+100.0%
0.00%
SVFAW NewSVF INVESTMENT CORP*w exp 12/20/202$104,00050,000
+100.0%
0.00%
NGABWS NewNORTHERN GENESIS ACQUISITION*w exp 01/15/202$107,00092,675
+100.0%
0.00%
SBTX ExitSILVERBACK THERAPEUTICS INC$0-47,620
-100.0%
-0.01%
IVA ExitINVENTIVA SAads$0-160,000
-100.0%
-0.01%
ALPN ExitALPINE IMMUNE SCIENCES INC$0-200,000
-100.0%
-0.02%
FDMT Exit4D MOLECULAR THERAPEUTICS IN$0-100,000
-100.0%
-0.02%
MASS Exit908 DEVICES INC$0-75,000
-100.0%
-0.03%
HMCOU ExitHUMANCO ACQUISITION CORPunit 12/08/2023$0-400,000
-100.0%
-0.03%
ISEE ExitIVERIC BIO INC$0-754,740
-100.0%
-0.03%
STTK ExitSHATTUCK LABS INC$0-100,000
-100.0%
-0.03%
MRVL ExitMARVELL TECHNOLOGY GROUP LTDcall$0-125,000
-100.0%
-0.04%
ACIA ExitACACIA COMMUNICATIONS INC$0-100,000
-100.0%
-0.04%
CASU ExitCASCADE ACQUISITION CORPunit 99/99/9999$0-990,000
-100.0%
-0.06%
TINVU ExitTIGA ACQUISITION CORPunit 99/99/9999$0-1,080,000
-100.0%
-0.07%
NTLA ExitINTELLIA THERAPEUTICS INC$0-225,000
-100.0%
-0.07%
XPO ExitXPO LOGISTICS INC$0-110,000
-100.0%
-0.08%
PRAX ExitPRAXIS PRECISION MEDICINES I$0-250,000
-100.0%
-0.08%
BMYRT ExitBRISTOL-MYERS SQUIBB COright 99/99/9999$0-21,400,000
-100.0%
-0.09%
BMY ExitBRISTOL-MYERS SQUIBB CO$0-250,000
-100.0%
-0.09%
PANA ExitPANACEA ACQUISITION CORPcl a$0-2,500,000
-100.0%
-0.18%
PACB ExitPACIFIC BIOSCIENCES CALIF IN$0-2,100,000
-100.0%
-0.33%
ABBV ExitABBVIE INC$0-1,150,000
-100.0%
-0.74%
TIF ExitTIFFANY & CO NEW$0-2,287,000
-100.0%
-1.81%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Farallon Capital Europe #1
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-17
  • View 13F-HR/A filed 2021-08-13
  • View 13F-HR/A filed 2021-11-15
  • View 13F-HR/A filed 2022-02-14
  • View 13F-HR/A filed 2022-05-16
  • View 13F-HR/A filed 2022-05-19
  • View 13F-HR/A filed 2022-08-15
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MICROSOFT CORP41Q3 20233.7%
RADIUS HEALTH INC33Q2 20221.7%
GRIFOLS S A33Q4 20210.9%
ALPHABET INC32Q3 20234.2%
SPDR S&P 500 ETF TR31Q3 202325.3%
VISA INC30Q3 20232.9%
WABTEC CORP27Q3 20233.6%
EXELIXIS INC27Q3 20232.8%
ELEVANCE HEALTH INC26Q3 20232.6%
SAVARA INC26Q3 20230.3%

View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.

Latest significant ownerships (13-D/G)
FARALLON CAPITAL MANAGEMENT LLC Q1 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Atento S.A.March 15, 20232,230,35715.4%
Metals Acquisition CorpFebruary 07, 20232,489,7009.4%
Inflection Point Acquisition Corp.February 06, 20231,900,0005.8%
AMYRIS, INC.February 24, 20221,068,9040.3%
Swiftmerge Acquisition Corp.February 14, 2022291,0601.3%
Caribou Biosciences, Inc.February 11, 20222,428,1504.0%
ENANTA PHARMACEUTICALS INCFebruary 11, 2022287,0001.4%
Protagonist Therapeutics, IncFebruary 11, 2022387,0510.8%
Solid Power, Inc.February 11, 2022? ?
Better Therapeutics, Inc.February 09, 2022124,0650.5%

View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR2024-02-14
13F-HR/A2024-02-12
SC 13G/A2024-02-01
SC 13G/A2024-01-23

View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (20124185000.0 != 20124191000.0)
  • The reported has been amended

Export FARALLON CAPITAL MANAGEMENT LLC's holdings